TECHNOLOGY SUMMARY
1 — 19
AREA/MATURITY/AWARDS
Primary Application Area: Startup Technology Company
Technology Development Status: A shelf-stable, off-the-shelf skin substitute engineered with preserved blood vessel structures and
Technology Readiness Level:
Vetted Programs/Awards: 1. NY I-Corps (2024) and NSF I-Corps (2025) 2. Awarded funding from The Mathers Foundation ($646K) and SUNY Technology Accelerator Fund (TAF) ($50K) (both 2025) 3. Venture Champions Competition Winner (2024)
MARKET KEYWORDS
Market Keywords: Tissue engineering, Skin substitute, Vascularized biomaterials